Cardio-metabolic risks in preterm children: opportunities, cautions and the importance of longer-term study

Hanis Hidayu Kasim1, Raul Chavez-Valdez2, Divyen K Shah3,4

  • 1Basic Medical Science 1, University Sains Islam Malaysia, Negeri Sembilan, Malaysia.

Pediatric Research
|March 18, 2026
PubMed

Insights

Future research on preterm children is crucial for understanding growth and metabolic health, supporting the developmental origins of health and disease (DOHaD) concept. Careful methodology is needed for reliable clinical insights.

Area of Science:

  • Pediatrics
  • Developmental Biology
  • Metabolic Health

Background:

  • Preterm birth impacts long-term health, with limited understanding of growth and metabolic needs as children age.
  • The developmental origins of health and disease (DOHaD) framework suggests early life influences later health outcomes.
  • Existing knowledge gaps hinder accurate interpretation of physiological responses in preterm populations.

Purpose of the Study:

  • To emphasize the need for prospective studies in aging preterm populations.
  • To highlight the importance of characterizing growth trajectories and metabolic profiles.
  • To underscore the necessity of addressing methodological challenges in assessments.

Main Methods:

  • This commentary reviews existing literature and identifies research needs.
  • It discusses the significance of prospective longitudinal studies.
  • It addresses challenges in anthropometric and metabolic assessments.

Main Results:

  • Prospective research is essential to define growth patterns in preterm children.
  • Understanding metabolic demands is critical for preterm populations.
  • Methodological rigor is required for valid clinical applications.

Conclusions:

  • Further prospective research is vital for preterm children's long-term health.
  • Characterizing growth and metabolism supports the DOHaD concept.
  • Careful consideration of assessment methods ensures reliable clinical guidance.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
647
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
426